NJ State Employees Deferred Compensation Plan’s TG Therapeutics TGTX Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-91,600	Closed	-$3.31M	–	367
2025 Q3	$3.31M	Hold	91,600	–	–	0.37%	55
2025 Q2	$3.3M	Hold	91,600	–	–	0.39%	54
2025 Q1	$3.61M	Hold	91,600	–	–	0.46%	46
2024 Q4	$2.76M	Hold	91,600	–	–	0.34%	66
2024 Q3	$2.14M	Hold	91,600	–	–	0.25%	93
2024 Q2	$1.63M	Hold	91,600	–	–	0.2%	109
2024 Q1	$1.39M	Hold	91,600	–	–	0.18%	127
2023 Q4	$1.56M	Hold	91,600	–	–	0.22%	105
2023 Q3	$766K	Buy	91,600 +19,000	+26%	+$265K	0.12%	189
2023 Q2	$1.8M	Hold	72,600	–	–	0.26%	89
2023 Q1	$1.09M	Hold	72,600	–	–	0.17%	143
2022 Q4	$859K	Hold	72,600	–	–	0.14%	169
2022 Q3	$430K	Buy	72,600 +45,600	+169%	+$299K	0.07%	274
2022 Q2	$115K	Hold	27,000	–	–	0.02%	450
2022 Q1	$257K	Hold	27,000	–	–	0.03%	420
2021 Q4	$513K	Hold	27,000	–	–	0.06%	295
2021 Q3	$899K	Hold	27,000	–	–	0.12%	181
2021 Q2	$1.05M	Hold	27,000	–	–	0.14%	159
2021 Q1	$1.3M	Hold	27,000	–	–	0.19%	128
2020 Q4	$1.41M	Hold	27,000	–	–	0.22%	108
2020 Q3	$723K	Hold	27,000	–	–	0.13%	158
2020 Q2	$526K	Hold	27,000	–	–	0.1%	204
2020 Q1	$266K	Hold	27,000	–	–	0.06%	310
2019 Q4	$300K	Hold	27,000	–	–	0.05%	397
2019 Q3	$152K	Buy	+27,000	New	+$188K	0.03%	494

Other funds holding TGTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's TGTX Position: Q4 2025 in Review

NJ State Employees Deferred Compensation Plan sold out of TG Therapeutics (TGTX) in Q4 2025, closing a stake of 91,600 shares — an estimated $3.31M sold.

NJ State Employees Deferred Compensation Plan first reported a position in TGTX in Q3 2019 and held it in 25 quarters. The position peaked at $3.61M in Q1 2025. 351 funds tracked by Wall St. Rank hold TGTX as of Q4 2025.

NJ State Employees Deferred Compensation Plan reported no remaining TG Therapeutics position as of Q4 2025 after selling out during the quarter.
NJ State Employees Deferred Compensation Plan sold 91,600 TG Therapeutics shares in Q4 2025, an estimated $3.31M.
NJ State Employees Deferred Compensation Plan first reported a position in TG Therapeutics in Q3 2019 and held it in 25 quarters.
NJ State Employees Deferred Compensation Plan's TG Therapeutics position peaked at $3.61M in Q1 2025.
351 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2025.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2025.